Table 1.

Measurements of expression of biomarkers in cardiovascular diseases and healthy controls.

Variables	Control	Patients	P value (P < 0.05)
Stress variable biomarkers
MDA (nmol/ml)	1.36 ± 0.031	5.44 ± 1.09	0.018
Nitric oxide (ng/ml)	19.19 ± 2.31	55.72 ± 2.16	0.011
Ages (ng/ml)	0.85 ± 0.04	2.74 ± 0.25	0.000
AOPPS (ng/ml)	83.05 ± 7.31	132.07 ± 13.79	0.011
eNOS (U/L)	11.28 ± 1.34	15.5 ± 1.64	0.004
Lipid profile biomarkers
Total cholesterol (mmol/L)	4.45 ± 0.971	5.48 ± 0.33	0.047
Triglycerides (mmol/L)	1.24 ± 0.15	2.59 ± 0.53	0.037
LDL (mmol/L)	2.31 ± 0.091	2.47 ± 0.19	0.013
HDL (mmol/L)	1.74 ± 0.017	1.39 ± 0.031	0.017
Inflammatory biomarkers
IL-Iα (pg/ml)	5.68 ± 0.53	6.64 ± 0.78	0.081
TNF-α (pg/ml)	29.57 ± 2.12	32.16 ± 3.79	0.017
MMP-11 (ng/ml)	45.6 ± 2.71	98.69 ± 7.77	0.017
Anti-oxidative biomarkers
SOD (µg/ml)	0.46 ± 0.003	0.24 ± 0.0021	0.041
Glutathione (µg/ml)	9.77 ± 1.73	4.91 ± 0.077	0.036
Catalase (µmol/mol of protein)	4.27 ± 0.007	1.43 ± 0.011	0.018
Vitamin E (µg/ml)	2.95 ± 0.66	2.19 ± 0.73	0.010
GPx (µmol/ml)	1.59 ± 0.007	2.33 ± 0.021	0.023
GRx (µmol/ml)	7.3 ± 1.67	6.03 ± 1.21	0.029